Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Castle Biosciences Inc (CSTL)

Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Why Castle Biosciences Stock Is Jumping Today Motley Fool - Thu Aug 3, 2023

The genetic-testing company beat expectations with its Q2 results.

CSTL : 24.41 (+0.33%)
Why Shares of Castle Biosciences Fell This Week Motley Fool - Thu Jul 13, 2023

Reactions to insider selling by two key leaders sent the stock down for a fourth consecutive day.

CSTL : 24.41 (+0.33%)
First Solar, Castle Biosciences rise; Levi Strauss falls, Friday, 7/7/2023 Associated Press - Fri Jul 7, 2023

Stocks that traded heavily or had substantial price changes on Friday: First Solar, Castle Biosciences rise; Levi Strauss falls

BABA : 81.55 (+0.27%)
SCCO : 118.04 (+2.28%)
MPC : 182.78 (+0.13%)
NEM : 41.39 (+1.80%)
FSLR : 193.81 (+1.18%)
LEVI : 22.16 (+0.73%)
SEDG : 60.07 (-0.63%)
CSTL : 24.41 (+0.33%)
Why Castle Biosciences Stock Is Crushing It Today Motley Fool - Fri Jul 7, 2023

The company received some unexpected good news.

CSTL : 24.41 (+0.33%)
Why Shares of Castle Biosciences Plummeted on Monday Motley Fool - Mon Jun 5, 2023

Analysts downgraded their price target for the medical diagnostics stock.

CSTL : 24.41 (+0.33%)
Why Shares of Castle Biosciences Slumped This Week Motley Fool - Fri Jun 2, 2023

Investors were unimpressed by the company's study regarding its IDgenetix test.

CSTL : 24.41 (+0.33%)
Castle Biosciences Reports First Quarter 2023 Results Business Wire - Wed May 3, 2023

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results for the first quarter ended March 31, 2023.

CSTL : 24.41 (+0.33%)
Study Demonstrates Use of DecisionDx®-Melanoma to Guide Treatment Decisions Resulted in Earlier Detection of Melanoma with Decreased Metastatic Tumor Burden Compared to Patients Without Surveillance Imaging Studies Business Wire - Wed May 3, 2023

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication of an independent, multi-center study in the Archives...

CSTL : 24.41 (+0.33%)
Castle Biosciences Collaborates with IMPACT Melanoma to Provide Free Sunscreen to Cyclists Participating in the Bike MS: Texas MS 150 2023 Cycling Event Business Wire - Fri Apr 28, 2023

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has teamed up with IMPACT Melanoma, one of the nation's leading...

CSTL : 24.41 (+0.33%)
DecisionDx®-Melanoma Provides Improved Risk Stratification Over American Joint Committee on Cancer (AJCC) Staging Alone in Stage I Melanoma Patients Business Wire - Tue Apr 25, 2023

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data showing DecisionDx ® -Melanoma can improve risk stratification...

CSTL : 24.41 (+0.33%)

Barchart Exclusives

After Its Historic Dividend Cut, Is 3M Stock Still Worth Buying? Barchart - Mon May 6, 6:30PM CDT
3M stock is a Dividend King no more, as the company slashed its payout following the Solventum spinoff. Is the stock still a buy for investors seeking passive income? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot